107 related articles for article (PubMed ID: 36152754)
1. Quantitative Phosphoproteomics Analysis Uncovers PAK2- and CDK1-Mediated Malignant Signaling Pathways in Clear Cell Renal Cell Carcinoma.
Senturk A; Sahin AT; Armutlu A; Kiremit MC; Acar O; Erdem S; Bagbudar S; Esen T; Ozlu N
Mol Cell Proteomics; 2022 Nov; 21(11):100417. PubMed ID: 36152754
[TBL] [Abstract][Full Text] [Related]
2. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
Huang J; Wang X; Wen G; Ren Y
Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
[TBL] [Abstract][Full Text] [Related]
5. Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).
Li W; Liu M; Feng Y; Xu YF; Huang YF; Che JP; Wang GC; Yao XD; Zheng JH
Br J Cancer; 2014 Sep; 111(6):1188-200. PubMed ID: 25010867
[TBL] [Abstract][Full Text] [Related]
6. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
[TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
8. CDK1/FBXW7 facilitates degradation and ubiquitination of MLST8 to inhibit progression of renal cell carcinoma.
Zhang E; Chen S; Tang H; Fei C; Yuan Z; Mu X; Qin Y; Liu H; Fan Y; Tan M; Wang X
Cancer Sci; 2022 Jan; 113(1):91-108. PubMed ID: 34741373
[TBL] [Abstract][Full Text] [Related]
9. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
[TBL] [Abstract][Full Text] [Related]
10. Underexpression of tumour suppressor LKB1 in clear cell renal cell carcinoma is common and confers growth advantage in vitro and in vivo.
Duivenvoorden WC; Beatty LK; Lhotak S; Hill B; Mak I; Paulin G; Gallino D; Popovic S; Austin RC; Pinthus JH
Br J Cancer; 2013 Feb; 108(2):327-33. PubMed ID: 23322200
[TBL] [Abstract][Full Text] [Related]
11. A Zic2/Runx2/NOLC1 signaling axis mediates tumor growth and metastasis in clear cell renal cell carcinoma.
Wu CY; Li L; Chen SL; Yang X; Zhang CZ; Cao Y
Cell Death Dis; 2021 Mar; 12(4):319. PubMed ID: 33767130
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
[TBL] [Abstract][Full Text] [Related]
13. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.
Wang J; Wang C; Xu P; Li X; Lu Y; Jin D; Yin X; Jiang H; Huang J; Xiong H; Ye F; Jin J; Chen Y; Xie Y; Chen Z; Ding H; Zhang H; Liu R; Jiang H; Chen K; Yao Z; Luo C; Huang Y; Zhang Y; Zhang J
Theranostics; 2021; 11(11):5387-5403. PubMed ID: 33859753
[No Abstract] [Full Text] [Related]
14. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-specific protease-44 inhibits the proliferation and migration of cells via inhibition of JNK pathway in clear cell renal cell carcinoma.
Zhou J; Wang T; Qiu T; Chen Z; Ma X; Zhang L; Zou J
BMC Cancer; 2020 Mar; 20(1):214. PubMed ID: 32164618
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive profiling of circRNAs and the tumor suppressor function of circHIPK3 in clear cell renal carcinoma.
Li H; Heng B; Ouyang P; Xie X; Zhang T; Chen G; Chen Z; Cheang K; Lai C
J Mol Histol; 2020 Jun; 51(3):317-327. PubMed ID: 32409849
[TBL] [Abstract][Full Text] [Related]
17. METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression.
Liu Z; Sun T; Piao C; Zhang Z; Kong C
J Transl Med; 2021 May; 19(1):209. PubMed ID: 33985542
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of
Yang CA; Huang HY; Yen JC; Chang JG
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29843367
[TBL] [Abstract][Full Text] [Related]
19. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
20. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY
Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
